TABLE 5.
ESB-genotype-negative bloodstream-infection Escherichia coli resistance phenotypes and characterization of transconjugants.
| Strain | MLST | PG | PRT | ESBL |
MIC |
Transfer |
Transconjugants |
|||||||
| ATM | FEP | CTX | CAZ | CZO | FOX | Resistance cotransferred | ESBL | PRT | ||||||
| EC-5 | ST730 | B2 | ND | − | ≤2 | ≤2 | ≤1 | ≤1 | ≤4 | ≤8 | − | |||
| EC-8 | ST1 | B2 | ND | + | >16 | >16 | >32 | >16 | >16 | ≤8 | + | ATMR,FEPR, CTXR,CAZR, CZOR | + | ND |
| EC-10 | ST31 | B2 | FrepB,K | + | >16 | >16 | >32 | >16 | >16 | 16 | + | ATMR,CTXR, CZOR | NT | FrepB |
| EC-11 | ST681 | B2 | ND | + | >16 | ≤8 | ≤2 | 4 | ≤8 | ≤8 | − | |||
| EC-12 | ST51 | B1 | ND | − | ≤2 | ≤2 | ≤1 | ≤1 | ≤4 | ≤8 | − | |||
| EC-14 | ST51 | B2 | FrepB,K | + | >16 | >16 | >32 | 8 | >16 | ≤8 | + | CZOR | + | FrepB |
| EC-15 | ST117 | B2 | ND | − | ≤8 | ≤8 | ≤2 | ≤1 | ≤8 | ≤8 | − | |||
| EC-17 | ST45 | B1 | ND | − | ≤2 | ≤2 | ≤1 | ≤1 | ≤4 | ≤8 | − | |||
| EC-19 | ST48 | B2 | ND | − | ≤2 | ≤2 | ≤1 | ≤1 | ≤4 | ≤8 | − | |||
| EC-22 | ST2 | A | ND | − | ≤2 | ≤2 | ≤1 | ≤1 | ≤4 | ≤8 | − | |||
| EC-30 | ST681 | B1 | ND | − | ≤2 | ≤2 | ≤1 | ≤1 | ≤4 | ≤8 | − | |||
| EC-34 | ST2 | D | ND | − | ≤8 | ≤8 | ≤2 | ≤1 | ≤8 | ≤8 | − | |||
| EC-40 | ST117 | D | FIB,FrepB,I1,K | + | >16 | 16 | >32 | >16 | >16 | ≤8 | + | CZOR | + | FrepB |
| EC-44 | ST2 | D | FIB,FrepB,K | + | >16 | >16 | >32 | >16 | >16 | ≤8 | + | ATMR,FEPR, CTXR,CZOR | + | FrepB |
| EC-45 | ST2 | B2 | FIA,FIB,K | + | 16 | >16 | >32 | 4 | >16 | ≤8 | + | − | + | ND |
| EC-46 | ST2 | D | FrepB,K | − | ≤2 | ≤2 | ≤1 | ≤1 | ≤4 | ≤8 | + | − | FrepB | |
| EC-47 | ST45 | B2 | ND | − | ≤2 | ≤2 | ≤1 | ≤1 | ≤4 | ≤8 | − | |||
PG, phylogenetic group; PRT, plasmid replicon type; MIC, minimum inhibitory concentration.